Aristotle University Of Thessaloniki (AUTH)
Συσχέτιση των αρχικών εκδηλώσεων του συστηματικού ερυθηματώδη λύκου με τις εκδηλώσεις κατά την πορεία της νόσου σε περίοδο 5 ετών
Abstract
dc:descriptionSystemic lupus erythematosus (SLE) is the most clinically and serologically diverse of the autoimmune connective tissue diseases because it may affect any organ of the body. However, some studies suggest that this condition can be divided into more homogenous subsets of pathogenetic, therapeutic, and prognostic significance. In the present retrospective study we have analyzed the prevalence and the characteristics of the most relevant clinical features at the diagnosis of the disease in 594 out of 743 data of patients with SLE that we collected. Median age of patients at the onset of the disease was 30 years; while at the diagnosis of SLE was 33 years. The ratio women/men was 10:1. The most frequent initial symptoms of the disease was arthralgia (62,6%), rash (47,3%), arthritis (43,7%) and fever (28%), whereas particularly increased was the frequency of manifestations which are not considered pathognomonic for SLE, according to the revised classification criteria for SLE, like Raynaud phenomenon (23,3%) and lymphadenopathy (12,9%). Several differences in the expression of the disease were found in relation to the gender, the age of the patient at the diagnosis of the disease and the initial laboratories findings. For instance, women had more frequently arthralgia, hair loss, Raynaud phenomenon and photosensitivity as initial clinical manifestations, whereas men had higher prevalence of thrombosis, nephropathy and strokes. A high title of positive αντιdsDNA αντιbodies was associated to higher prevalence of weight loss, fever, arthritis and lymphadenopathy and a lower prevalence of ocular symptoms. Relevant associations were also made for the other immunologic parameters. The main clinical manifestations of SLE during the 5-year period of follow-up were arthritis, neurological involvement, active nephropathy, Raynaud phenomenon, photosensitivity and serositis. Infection, hypertension and osteoporosis were the most frequent associated medical problems. Malignancies were developed only in 2 patients (0,4%). Furthermore associations that presented statistically importance were found between morbidity during the 5-year period and gender, age at diagnosis and initial immunological findings. The patients with the onset of the disease before the age of 14 years old had a statistically significant higher prevalence of fever, rash, particularly butterfly rash, lymphadenopathy, epistaxis and ulorrhagia. On the contrary there was a decreased prevalence of discoid lesions, photosensitivity, arthralgia and Raynaud phenomenon. At the diagnosis of the disease this group exhibited a higher prevalence of positive αντιdsDNA αντιbodies, low C4 and high SGOT. During the 5-year period of follow-up a statistically significant higher incidence of active nephropathy, epistaxis, ulorrhagias, thrombopenia as well as infections and cataracts was observed. On the contrary the incidence of osteoporosis was lower. The patients with the onset of the disease after the age of 50 years old less often showed malar rash, nephropathy, fever, lymphadenopathy and arthritis as the first symptom. On the other hand, these patients had more often lung involvement, pericarditis and sicca syndrome. The erythrocyte sendimantation rate was usually high at the diagnosis of the disease in this group. During the 5-year period of follow-up these patients appeared rarely active nephropathy, whereas they had a higher incidence in statistically significant levels of photosensitivity, hypertension, osteoporosis, retinopathy and non Hodgkin lymphoma. In conclusion, this study has shown that SLE has a wide spectrum of manifestations, of which some are not considered to be characteristics of the disease. In addition it was demonstrated that it is possible to recognize relatively homogeneous SLE subsets of clinical significance. Furthermore, our study has provided updated information of SLE morbidity characteristics in the present decade and has defined several clinical and immunologic prognostic factors. Assessing the incidence rates and delineating the prognostic factors associated with morbidity will be helpful for future management of patients with SLE using evidence-based medicine models.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stefanidou, Styliani
- Στεφανίδου, Στυλιανή
Subjects
dc:subject × 17- Συστηματικός Ερυθηματώδης Λύκος (ΣΕΛ)
- Προγνωστικοί παράγοντες
- Επιδημιολογία ΣΕΛ
- Συστηματικός ερυθηματώδης λύκος στους άνδρες
- Συστηματικός ερυθηματώδης λύκος στη παιδική ηλικία
- Συστηματικός ερυθηματώδης λύκος στους ηλικιωμένους
- Systemic lupus erythematosus (SLE)
- SLE DISEASE ACTIVITY
- Systemic lupus erythematosus in male
- Systemic lupus erythematosus in childhood
- Systemic lupus erythematosus in elderly
- Prognostic factors of SLE
- Epidemiology of SLE
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25625